New York, NY -- (SBWIRE) -- 05/20/2019 -- Orthobiologics, involve the use of biological substances to facilitate the quicker healing of musculoskeletal injuries. The substances used by orthopedic surgeons to make the healing of injuries faster are called orthobiologics. Orthobiologics are made by substances that are already found in the human body, they can help to make broken bones, tendons and ligaments heal better. When orthobiologic substances are used in a higher concentration, they can also help to pick up the healing process.

**Access Sample PDF @ https://www.marketindustryreports.com/pdf/2

The increase in the number of sports-related injuries and road accidents, the technological advancements in the regenerative medicine and stem cell therapy arena, high incidence of musculoskeletal disorders and the rising prevalence of spine-related surgeries are major factors driving the Orthobiologics market. The high costs related to orthobiologics products and surgeries, however, are likely to restrain the market. The major leading players in the global orthobiologics market are Medtronic, Bioventus, Arthrex, Seikagaku, DePuySynthes, Zimmer Biomet, MTF, Sanofi and NuVasive among others.

Scope of the Report: The study relies heavily on both qualitative and quantitative to generate, interpret and analyze raw data about the target market, product or services offered and prominent market players operating in the Orthobiologics market for the forecast period, 2019 - 2030. The new intelligence study further digs deep to extract all data pertaining to aspects such as production capability, spending power, customer preference and potential customers to offer usable business information. This report can be considered as a cautious assessment of the target customers, their requirements, geography generating maximum sales and potential distribution channel.

Table of Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Market Ecosystem
1.2.1. Market Classification
1.2.2. Geographic Scope
1.2.3. Years Considered for the Study
1.2.3.1. Historical Years – 2016 & 2017
1.2.3.2. Base Year – 2018
1.2.3.3. Forecasted Years – 2019 to 2030
1.3. Currency Used for the Study
1.4. Report Beneficiary List

2. RESEARCH METHODOLOGY

2.1. Research Framework
2.2. Data Collection Technique
2.3. Data Sources
2.3.1. Secondary Sources
2.3.2. Primary Sources
2.4. Market Estimation Methodology
2.4.1. Bottoms Up Approach
2.4.2. Top Down Approach
2.5. Data Validation and Triangulation
2.5.1. Market Forecasting Model
2.5.2. Limitations of the Study
2.5.3. Assumptions of the Study

#This Reports Includes Segmental analysis, Regional analysis, Research Methodology, Competitive Landscape, Learn how to build the strategy and business case to implement Order Here@ https://www.marketindustryreports.com/checkout/2

Increasing hip and knee replacement surgeries

Osteoarthritis is one of the most disabling diseases majorly in developed countries. Substantial advances in treatment and surgical methods have provided effective options to decrease the disability and pain associated with some of the musculoskeletal conditions. Hip and knee joint replacement surgery is considered as the most effective intervention for severe form of osteoarthritis and fractures, reducing disability and pain, also restoring some patients to normal function. According to the data published by the OECD Health Statistics, in 2017, hip replacement rate is increased by 30% between 2000 and 2015 while the rate of knee replacement doubled.

Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Orthobiologics Market by Product (Viscosupplementation, Allograft, Stem Cell Therapy, Demineralized Bone Matrix (DBM)), Application (Spinal Fusion, Reconstructive Surgery, Soft Tissue), End User (Hospitals, ASCs, Academia) End User (Hospital & Clinics, Ambulatory Care Centers & Orthopedic Clinics) - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/2/orthobiologics-market

The Top key vendors in Orthobiologics Market include are Smith & Nephew, B.Braun, ConvaTec Group, Integra Lifesciences, 3M, Cardinal Heatch, Medtronic, MPM Medical, Paul Hartmann, MiMedx Group

Rising R&D investment to widen the base for growth

Collaborations and rising R&D investments by the prominent biotechnology and medical device companies are leading to the introduction of advanced orthobiologics which is expected to widen the base for growth of the orthobiologics. For instance, Bone Biologics Corp., is in development stages of its orthobiological product bone growth stimulator Nell-1, in collaboration (2015) with the University of California. This subsequent increase in R&D efforts led to development of a series of pipeline products that is projected to provide the vertical with profitable growth opportunities in the future.

About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001

Email: sales@marketindustryreports.com

Phone: + 91 967-353-5933

Website: https://www.marketindustryreports.com/

Follow Us- LinkedIn | Twitter | Face book